Back to Journals » OncoTargets and Therapy » Volume 9

Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?

Total article views   Abstract views HTML views PDF downloads Totals
4,150 Dovepress* 3,027 789+ 677 3,816
PubMed Central* 0 334 100 334
Totals 3,027 1,123 777 4,150
*Since 11 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar